http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35870914

Outgoing Links

Predicate Object
contentType Journal Article
issn 1689-1392
issueIdentifier 1
pageRange 47-
publicationName Cellular & Molecular Biology Letters
startingPage 47
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_68cd2fe334a1a38a84cb6938816b1493
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bb4508f2d5fe90eda105eaec6bd9416b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f78731350469fd3fb08d6de7b6d974a8
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c6fa85d25406306f8026533a1dd8d7c5
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c3527fe9f29468850771890163306ddd
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a30ce4b9d12ec89fb7c92107397dadf1
bibliographicCitation Cheng LS, Zhu M, Gao Y, Liu WT, Yin W, Zhou P, Zhu Z, Niu L, Zeng X, Zhang D, Fang Q, Wang F, Zhao Q, Zhang Y, Shen G. An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity. Cell Mol Biol Lett. 2023 May 31;28(1):47. PMID: 37259060; PMCID: PMC10230818.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55f05fec251794a59ea2895c57c97f2a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_192d9174279edb6507d820b3b054f090
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_534a61a9600125d94ce88a3545503b39
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d44feaff4c123e8aab0054995e10d949
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60dbf8e6991681954ad132771259107c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6348d24cd07f20a4b712cbe039c55cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfe96fe28780b2ade9461166ac9556d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a04028d02c39a7507026df32c6c22111
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3b58a31b7ec3cbfb4e620b9f932c8a9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1157e553fa8fbdc8ae1ac85b13e02c43
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1660c738b92250264069c44151985b67
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cb2a264a0a2ac16cff88501da00de47
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2521-8738
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98cd98977d7eb1feb4ab467d1aca46bd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_caf259682c86da6b8380f4191a3c2e67
date 2023-05-31^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/37259060
https://doi.org/10.1186/s11658-023-00461-w
https://pubmed.ncbi.nlm.nih.gov/PMC10230818
isPartOf https://portal.issn.org/resource/ISSN/1689-1392
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/25486
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity
discusses http://id.nlm.nih.gov/mesh/M0556121
http://id.nlm.nih.gov/mesh/M0027219
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015179Q000378
http://id.nlm.nih.gov/mesh/D018033Q000494
http://id.nlm.nih.gov/mesh/D015179Q000188
http://id.nlm.nih.gov/mesh/D061026
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008252
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D007167
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D018414Q000378
http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_beda6fe677b7a43d27c994ffcbd5e2d6
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11167
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.13.12.8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c39dfa3c98491d25b749b54f8cf226ff
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b

Showing number of triples: 1 to 61 of 61.